Protection by Osbeckia aspera against carbon tetrachloride-mediated alterations in microsomal drug metabolizing

K A Jayatilaka1, M I Thabrew

  • 1Department of Biochemistry, Faculty of Medicine, University of Ruhuna, Sri Lanka.

Insights

Osbeckia aspera leaf extract protects against liver damage by reducing alterations in drug-metabolizing enzymes and inhibiting lipid peroxidation. The extract

Area of Science:

  • Pharmacology
  • Hepatoprotective Agents
  • Natural Product Chemistry

Background:

  • Carbon tetrachloride (CCl4) induces liver injury, primarily affecting endoplasmic reticulum and drug-metabolizing enzymes.
  • Aniline hydroxylase and p-aminopyrine N-demethylase are key microsomal enzymes sensitive to CCl4 toxicity.
  • Lipid peroxidation is a significant marker of CCl4-induced cellular damage.

Purpose of the Study:

  • To investigate the protective effects of Osbeckia aspera leaf extract against CCl4-induced liver injury.
  • To determine the impact of the extract on specific drug-metabolizing enzymes (aniline hydroxylase, p-aminopyrine N-demethylase).
  • To evaluate the extract's influence on phenobarbital-induced responses and lipid peroxidation.

Main Methods:

  • Administration of aqueous Osbeckia aspera leaf extract to rats before or after CCl4 exposure.
  • Measurement of aniline hydroxylase and p-aminopyrine N-demethylase activities.
  • Assessment of phenobarbital-induced righting reflex duration and malondialdehyde (MDA) levels for lipid peroxidation.

Main Results:

  • Osbeckia aspera extract significantly reduced CCl4-induced alterations in enzyme activities.
  • The extract mitigated CCl4-mediated lipid peroxidation, indicated by lower MDA formation.
  • Phenobarbital-induced sleeping time was normalized, and enzyme kinetics (Km values) remained unchanged, suggesting no induction or alteration of enzyme affinity.

Conclusions:

  • Osbeckia aspera leaf extract demonstrates significant hepatoprotective effects against CCl4-induced liver damage.
  • The extract protects liver cells by preserving drug-metabolizing enzyme function and inhibiting oxidative stress.
  • The protective mechanism does not involve enzyme induction or altered substrate affinity, highlighting a unique mode of action.

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Acetals and Thioacetals as Protecting Groups for Aldehydes and Ketones01:24

Acetals and Thioacetals as Protecting Groups for Aldehydes and Ketones

Acetals are formed by reacting two equivalents of alcohol with carbonyl compounds like aldehydes or ketones. Acetals are unaffected by bases, nucleophiles, oxidizing agents, and reducing agents. They serve as protecting groups for aldehydes and ketones. Acetals can be easily formed and also easily removed via mild acid hydrolysis.
In the presence of multiple functional groups, when selective reduction of one group over the other is desired, groups like aldehydes and ketones that form acetals...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...